XELLIA PHARMACEUTICALS ApS: Financial statements 2025
CVR: 61094628
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
XELLIA PHARMACEUTICALS ApS (CVR 61094628) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,461,516,000 and a net result of DKK 213,738,000 compared with DKK 828,966,000 the year before. That is a decrease of 8.6% compared with the year before. The profit margin was 14.6%. Equity in the 2025 report amounted to DKK 404,569,000. The solvency ratio was 14.3%. The company had 453 employees in the financial year.
- Revenue
- DKK 1,461,516,000
- Gross Profit
- DKK 314,911,000
- Profit/Loss
- DKK 213,738,000
- Equity
- DKK 404,569,000
- Total Assets
- DKK 2,829,479,000
- Employees
- 453
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1.5B | 314.9M | 213.7M | 404.6M | 453 |
| 2024 | 1.6B | 37M | 829M | 162.5M | 547 |
| 2023 | 2B | -640.2M | -2.4B | -597.8M | 650 |
| 2022 | 2.2B | 318.4M | -371.5M | 1.8B | 648 |
| 2021 | 1.8B | -47M | -503.1M | 2.1B | 640 |
Official annual report
How creditworthy is XELLIA PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
XELLIA PHARMACEUTICALS ApS has published its annual report for 2024. Revenue came to DKK 1,599,382,000, and the net result was DKK 828,966,000.
As of April 30, 2025, Eva Blem has joined the board of directors of XELLIA PHARMACEUTICALS ApS.
As of April 30, 2025, Bente Schmidt Nielsen has left the board of directors of XELLIA PHARMACEUTICALS ApS.
About XELLIA PHARMACEUTICALS ApS
XELLIA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København S, founded in 1959. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named AXELLIA PHARMACEUTICALS ApS and ALPHARMA ApS. The management consists of Michael Kocher. The board consists of Søren Hostrup (chair), Alexander Sebastian Benjamin Sproedt, Hugo Mendes Marques Crespo Dos Reis and Lars Beck Madsen. The company is owned by XELLIA GROUP ApS. The company has 461 employees (2026). In 2025, the company reported revenue of DKK 1,461,516,000 and a net result of DKK 213,738,000 compared with DKK 828,966,000 the year before. Equity in the 2025 report amounted to DKK 404,569,000.
